HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Selda Gezginci-Oktayoglu Selected Research

Inflammation (Inflammations)

10/2021Vitamin U prevents valproic acid-induced liver injury through supporting enzymatic antioxidant system and increasing hepatocyte proliferation triggered by inflammation and apoptosis.
11/20184-Methylcatechol prevents streptozotocin-induced acute kidney injury through modulating NGF/TrkA and ROS-related Akt/GSK3β/β-catenin pathways.
7/2016Prostaglandin-E1 has a protective effect on renal ischemia/reperfusion-induced oxidative stress and inflammation mediated gastric damage in rats.
1/2016Vitamin U has a protective effect on valproic acid-induced renal damage due to its anti-oxidant, anti-inflammatory, and anti-fibrotic properties.
1/2015Exendin-4 attenuates renal tubular injury by decreasing oxidative stress and inflammation in streptozotocin-induced diabetic mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Selda Gezginci-Oktayoglu Research Topics

Disease

5Inflammation (Inflammations)
10/2021 - 01/2015
3Hypoxia (Hypoxemia)
02/2024 - 02/2023
3Hyperglycemia
11/2022 - 01/2014
3Fibrosis (Cirrhosis)
01/2022 - 01/2015
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
02/2024 - 11/2022
2Necrosis
01/2023 - 04/2010
2Diabetic Nephropathies (Diabetic Nephropathy)
01/2022 - 01/2015
2Lung Injury
01/2018 - 01/2010
1Poisoning
01/2023
1Cardiotoxicity
01/2023
1Autoimmune Diseases (Autoimmune Disease)
11/2022
1Edema (Dropsy)
01/2022
1Adenocarcinoma
07/2021
1Neoplasms (Cancer)
07/2021
1Type 2 Diabetes Mellitus (MODY)
12/2018
1Acute Kidney Injury (Acute Renal Failure)
11/2018
1Pulmonary Edema
01/2018
1Atherosclerosis
01/2018
1Body Weight (Weight, Body)
02/2013

Drug/Important Bio-Agent (IBA)

3Conditioned Culture MediaIBA
01/2024 - 01/2022
3Exenatide (Byetta)FDA Link
01/2022 - 01/2015
3Streptozocin (Streptozotocin)FDA Link
11/2018 - 01/2015
2Deferoxamine (Desferal)FDA LinkGeneric
02/2024 - 01/2022
2Insulin (Novolin)FDA Link
11/2022 - 01/2018
2CytokinesIBA
11/2022 - 01/2015
2Valproic Acid (Depakote)FDA LinkGeneric
10/2021 - 01/2016
2AntioxidantsIBA
10/2021 - 01/2014
2Vitamin U (S-Methylmethionine)IBA
10/2021 - 01/2016
2Glucose (Dextrose)FDA LinkGeneric
07/2021 - 01/2018
2CateninsIBA
12/2018 - 11/2018
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2010 - 01/2010
2GalactosamineIBA
04/2010 - 01/2010
2MDL 201053IBA
04/2010 - 01/2010
1oxalylglycineIBA
01/2024
1Oxygen (Dioxygen)IBA
02/2023
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2023
1(1- pentyl- 1H- indol- 3- yl)(2,2,3,3- tetramethylcyclopropyl)methanoneIBA
01/2023
1Troponin T (Troponin T1)IBA
01/2023
1Cannabinoid Receptor AgonistsIBA
01/2023
1EnzymesIBA
10/2021
1Aspartame (NutraSweet)IBA
07/2021
1Sweetening Agents (Sweeteners)IBA
07/2021
1SugarsIBA
07/2021
1Nerve Growth Factor (NGF)IBA
11/2018
14-methylcatecholIBA
11/2018
1Glucagon-Like Peptide-1 ReceptorIBA
01/2018
1Surface-Active Agents (Surfactants)IBA
01/2018
1CollagenIBA
01/2018
1Glucagon-Like Peptide 1 (GLP 1)IBA
01/2018
1Alprostadil (Muse)FDA LinkGeneric
07/2016
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2015
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
01/2015
1Fibronectins (Fibronectin)IBA
01/2015
1ChemokinesIBA
01/2015
1Corn Oil (Oil, Corn)IBA
02/2013
1Vitamin EFDA LinkGeneric
02/2013
1TaurineFDA Link
02/2013
1Alanine (L-Alanine)FDA Link
01/2010
1Cathepsin BIBA
01/2010

Therapy/Procedure

2Immunomodulation
02/2024 - 11/2022